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COMMENTARY
The Surprisingly Rich Contours
of Schizophrenia Epidemiology
R ESEARCHERS LIKETOBEsurprised by the data.When new data chal-lenge old beliefs, thefield becomes primed
for discovery. The aim of this com-
mentary is to let the broader psychi-
atric community know about recent
discoveries in schizophrenia epide-
miology, and to speculate on how
best to leverage these discoveries to
advance knowledge.
For those who do not follow the
literature closely, recent research in
the epidemiology of schizophrenia
may comeas a surprise. Theonce car-
dinal notions that schizophrenia af-
fects men andwomen equally and is
found in all societies with compa-
rable (or equal) incidence are no
longer supported by the data. Schizo-
phrenia is not the egalitarian disor-
der that we once thought it was.1
In this issue of the ARCHIVES,
Pera¨la¨ and colleagues2 report on
what is arguably the most thor-
ough study ever undertaken on the
prevalence of psychotic disorders.
Overall, the lifetime prevalence of
psychotic disorders in Finnish adults
was 3.48%. This is a startling pro-
portion. The lifetime prevalence of
nonaffective psychoses was 2.29%.
For schizophrenia, the lifetimepreva-
lence was 1%, which, while at the
higher end of the range,3 is compa-
rable to other studies from Finland.
Regardless of how we partition the
psychotic disorders, the survey by
Pera¨la¨ andcolleagues2 remindsus just
howcommonpsychotic disorders are
in the general population.While they
may be less prevalent than depres-
sion or substance abuse, we should
probably not mislead people by la-
beling psychoses as low-prevalence
disorders.
Apart from enumerating cases,
what else has epidemiology taught
us about schizophrenia? The short
message is this: the epidemiology of
schizophrenia is no longer a flat and
featureless horizon.4 In its place we
find that the epidemiological hori-
zon of schizophrenia5 is muchmore
interesting than previously sus-
pected. There are rich and informa-
tive gradients that can guide future
research. For example, a recent sys-
tematic review of the incidence of
schizophrenia (drawing on 1458 in-
cidence rates from 33 countries)
found prominent variation in the in-
cidence of schizophrenia between
sites (5-fold), and a skewed dis-
tribution of rates, with many high
rates in the upper tail of the distri-
bution.6 These data challenge the
equal incidence notion promul-
gated after the publication of the
WorldHealthOrganization TenNa-
tion Study.7
Despite what we read in text-
books anddiagnosticmanuals, the in-
cidence of schizophrenia is different
in men and women. Two systematic
reviews have provided convergent
evidence that themale-female rate ra-
tio is 1.4:1.6,8 The male excess per-
sists even when factors such as age
rangeanddiagnostic criteria are taken
into account.While this findingmay
surprise some, it will not come as a
surprise to clinicians. It will be in-
teresting to see how long it takes for
this important epidemiological fea-
ture to percolate into the textbooks
anddiagnosticmanuals. In themean-
time, we need to now teach that for
every 3 men who develop schizo-
phrenia, there are 2 women devel-
oping the disease.
There are several other startling
findings to emerge from the epide-
miology of schizophrenia. Some, but
not all, migrant groups have aston-
ishingly high rates of schizophre-
nia.6,9 This epidemic cannot be ex-
plained away by confounds related
to selective migration or method-
ological biases. Similarly, the evi-
dence is robust that those born
and/or raised in cities have an in-
creased risk of developing schizo-
phrenia compared with those born
and/or raised in rural regions.10-12 Re-
cently in the ARCHIVES, Kirkbride
and colleagues13 presented a 3-site
study of the incidence of schizo-
phrenia in England. Even when ac-
counting for migrant/ethnic status,
the incidence of psychosis was sig-
nificantly higher in London com-
pared with the other sites (Notting-
ham and Bristol). What is it about
migrant status or city life that in-
creases the risk of developing schizo-
phrenia? What are the candidate
exposures and what are the mecha-
nisms of action? Somewhat embar-
rassingly for our field, the quality of
the data linking urbanicity to schizo-
phrenia is now much stronger than
the quality of the hypotheses that
have been proposed to explain the
association. In part, the evidence
linking schizophrenia risk with mi-
grant status and urbanicity has con-
tributed to the current renaissance
of social psychiatry research in the
field.14,15
The list of curious findings in
schizophrenia epidemiology goes
on. Some long-standing clues have
becomemore precise, thanks to new
data and/or the application of sys-
tematic review and meta-analysis.
For example, there is an increased
risk of schizophrenia associatedwith
older paternal age,16,17 prenatal fam-
ine,18,19 winter/spring birth,20 higher
latitude,21 prenatal infection,22-25 and
pregnancy and birth complica-
tions.26
Why should we be surprised to
find that schizophrenia epidemiol-
ogy is so interesting and complex?
No one needs to be reminded about
the marked clinical and neurobio-
logical heterogeneity of the disor-
der.27 With respect to genetics, the
research community is now com-
fortable with the notion that there
See also page 19
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are many different susceptibility
genes, each of small effect,whichdis-
play variability between popula-
tions.28 These genetic factors (which
influence susceptibility and/or clini-
cal features29) are embedded in com-
plex causal pathways that involve a
dynamicmatrix of genetic and envi-
ronmental factors over develop-
ment.30 In light of the marked vari-
ability in both the phenotype and
genotype, one might predict similar
heterogeneity in environmental fac-
tors.Onemight also expect that these
environmental factorswould vary be-
tween sites and across time; they do
for most human diseases. Epidemi-
ology should be able to capture at
least some of these gradients.
What type of epidemiological re-
search needs to be done now? First
and foremost, the schizophrenia re-
search community needs to gener-
ate a sense of urgency about unrav-
eling the environmental risk factors
contributing to the gradients. Take,
for example, the fact that urban birth
is associatedwith a substantial (30%)
population-attributable risk.11 Popu-
lation demographics indicate in-
creasing urbanization in both the de-
veloped and developing world.31
While speculative, it is feasible that
the population-attributable frac-
tion of schizophrenia associatedwith
urban birth will rise in the decades
to come. By any standards, these are
startling projections that should gal-
vanize the research community. It is
interesting to speculate about what
the response would be if the health
outcome was cardiovascular dis-
ease rather thanmental illness. One
would predict that government
funding agencies would invest
heavily in projects aimed at under-
standing the mechanisms of action
linking the variables of interest.
(Think of the epidemic of cardio-
vascular disease in themid-20th cen-
tury and the Framingham Heart
study.) The fact that this has not yet
happened for schizophrenia is a
cause for concern. If the research
community responds to these new
epidemiological signals in a lethar-
gic and ataxic fashion, why should
funding agencies get excited?Weur-
gently need more research on un-
derstanding the mechanisms of
action underpinning the epidemio-
logical gradients of schizophrenia.
Second, we need to broaden our
categories of observation beyond
narrow diagnostic criteria to ex-
plore symptoms associatedwith psy-
chosis that can be found in other-
wise well individuals.32 Several large
community-based samples have
identified surprisingly high propor-
tions of the general community who
report hallucinations anddelusional-
like experiences.33,34 This type of re-
search can complement traditional
schizophrenia studies.
Third, we need to add value to fu-
ture epidemiological studies. Count-
ing heads purely for the purposes of
enumerationmay not be the best in-
vestment for the research dollar.35
While incidence and prevalence
studies can help service develop-
ment and identify unmet needs, the
return for the research dollar can be
enriched by including other infor-
mative variables (eg, blood for geno-
typing, neuroimaging, and neuro-
cognitive measures). While it may
not be feasible to collect such data
from all subjects in large descrip-
tive epidemiological studies, smaller
case-control studies can be nested
into the overall design. Needless to
say, if genetic factors influence or
mediate candidate environmental
exposures, then studies should seek
to measure these (see recent re-
views on mendelian randomiza-
tion36). Another way to add value is
to select the samples to amplify the
putative environmental exposure.
For example, if urbanicity is a risk
factor for schizophrenia, then this
should be more readily detected in
incidence studies conducted in very
large cities. The 3-center study from
Englandmentioned previously is an
intelligent example of this strategy,
as it was able to capture within-
country gradients in both urbanic-
ity and migrant status.13
Finally, and most importantly,
epidemiology needs to build stron-
ger links with molecular, cellular,
and behavioral neuroscience. This is
especially important when it comes
to progressing candidate risk fac-
tors derived from ecological stud-
ies. Epidemiology is a blunt instru-
ment when it comes to exploring
these questions; neuroscience is
needed to evaluate the biological
plausibility of candidate expo-
sures. However, modern neurosci-
ence is an intensely fertile and en-
ergetic discipline; thus it is unlikely
that signals that emerge from schizo-
phrenia epidemiology would ex-
cite this disciplinewithout some type
of affirmative action. The schizo-
phrenia research community needs
to generate candidate exposures and
test (and reject) these candidates
quickly and efficiently. For ex-
ample, if we think that particular
types of social stress contribute to the
association between migrant status
and risk of schizophrenia,37 we need
to engage the neuroscience commu-
nity to refine ourmodels from aneu-
robiological perspective.Which par-
ticular brain systems are most
vulnerable to which particular types
of stressors? What type of animal
models could be designed to assess
candidate exposures? Neurosci-
ence can help us refine our ques-
tions, which can then influence the
design and choice of exposuremea-
sures in future analytical (eg, case-
control) epidemiological studies.
However, we cannot expect the new
ideas currently being generated by
schizophrenia epidemiology to in-
fluence neurosciencemerely by pas-
sive osmosis. We need to build




Such dialogues can be reward-
ing for all parties. By way of dem-
onstration, based on various clues
from epidemiology (eg, season of
birth), our group proposed that de-
velopmental vitamin D deficiency
was a candidate risk–modifying fac-
tor for schizophrenia.38 Initially,
there was an absence of informa-
tion on the biological plausibility of
this candidate. However, animal ex-
periments have since confirmed that
transient lowprenatal vitaminD lev-
els cause a range of neuroscience
outcomes in the adult animal that are
informative for schizophrenia re-
search (eg, enlarged ventricles and
disrupted dopaminergic/glutamin-
ergic pathways).39-43 Clues from
schizophrenia epidemiology have
uncovered previously unsuspected
pathways involving vitamin D and
brain development.
Environmental risk factors clearly
contribute to the prominent varia-
tions in the incidence of schizophre-
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nia across time and place. The na-
ture of the exposures remains to be
clarified. Renewed interest in the en-
vironment and schizophrenia should
not be misread as somehow lessen-
ing the importance of genetic con-
tributions.44 Schizophrenia research-
ers, like those interested in the
etiology of chronic diseases in gen-
eral, have nature-vs-nurture fa-
tigue. The research community is
united in a sincere desire to unravel
the hidden layers of complexity un-
derpinning schizophrenia. We can-
not afford to waste the clues being
generated by epidemiology. Ac-
knowledging thevariations in the epi-
demiology of schizophrenia is liber-
ating; gradients in the incidence of
schizophrenia allow the researcher to
gain traction on these contours.45
There is a sense of expectancy in
schizophrenia epidemiology pres-
ently.Wecanonlyhope that this field
will continue to surprise us. If we are
lucky, these surprises will challenge
our preconceptions. As Niels Bohr
noted, “No paradox, no progress.”
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